Psychological Sexual Dysfunctions (Sexual Arousal Disorder)

Subscribe to Selected New Research on Psychological Sexual Dysfunctions

110 relevant articles (14 outcomes, 28 trials/studies) found for this Disease

Description: Disturbances in sexual desire and the psychophysiologic changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty. (APA, DSM-IV, 1994)

Also Known As:

Sexual Arousal Disorder; Frigidity; Psychosexual Disorder; Hypoactive Sexual Desire Disorder; Orgasmic Disorders; Orgasmic Disorder; Sexual Aversion Disorder; Sexual Dysfunctions, Psychological; Arousal Disorders, Sexual; Aversion Disorders, Sexual; Disorder, Psychosexual; Disorders, Orgasmic; Disorders, Psychosexual; Disorders, Sexual Arousal; Disorders, Sexual Aversion; Dysfunction, Psychological Sexual; Dysfunction, Psychosexual; Dysfunctions, Psychological Sexual; Dysfunctions, Psychosexual; Psychological Sexual Dysfunction; Psychosexual Dysfunction; Sexual Arousal Disorders; Sexual Aversion Disorders; Sexual Dysfunction, Psychological; Psychosexual Disorders; Psychosexual Dysfunctions

Relationship Network

Disease Context: Research Results

Mental Disorders: 1709

Sexual and Gender Disorders

Psychological Sexual Dysfunctions: 110

Erectile Dysfunction: 4316

Related Diseases

1.	Psychological Sexual Dysfunctions (Sexual Arousal Disorder)
2.	Vaginismus
3.	Erectile Dysfunction
4.	Dyspareunia
5.	Syndrome

Experts

1.	Rodenberg, Cynthia: 5 articles (07/2007 - 07/2005)
2.	Buch, Akshay: 4 articles (09/2006 - 07/2005)
3.	Simon, James A: 2 articles (09/2008 - 07/2005)
4.	Goldstein, Irwin: 2 articles (09/2008 - 09/2008)
5.	Kingsberg, Sheryl: 2 articles (07/2007 - 03/2007)
6.	Wekselman, Kathryn: 2 articles (07/2007 - 09/2006)
7.	Beaumont, Kevin: 2 articles (01/2007 - 07/2006)
8.	Kohl, Christopher: 2 articles (01/2007 - 07/2006)
9.	Van Der Graaf, Piet: 2 articles (01/2007 - 07/2006)
10.	Stobie, Alan: 2 articles (01/2007 - 07/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Psychological Sexual Dysfunctions:

1.	Testosterone (Sustanon)FDA LinkGeneric 03/01/2008 - "Based upon our 1 year follow-up, low-dose testosterone is a safe and effective approach in treating hypoactive sexual desire disorder in a fragile X carrier female, provided the patient is monitored every 3 months for blood counts, lipid profiles, liver functions and free and total testosterone levels." 01/01/2007 - "In particular, the article focuses on testosterone therapy for hypoactive sexual desire disorder (a component of FSD), and the role of the Division of Reproductive and Urologic Products in facilitating the development of safe and effective therapies for this indication." 07/25/2005 - "Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial." 11/06/2008 - "METHODS: We conducted a double-blind, placebo-controlled, 52-week trial in which 814 women with hypoactive sexual desire disorder were randomly assigned to receive a patch delivering 150 or 300 microg of testosterone per day or placebo" 03/01/2008 - "To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application." Order ALL the reference details at left...
2.	sildenafil (Viagra)FDA Link 12/01/2003 - "For women with FSAD without concomitant hypoactive sexual desire disorder (HSDD) sildenafil was associated with significantly greater improvement in 5 of 6 FIEI items compared with placebo (p <0.02)" 05/01/2006 - "OBJECTIVE: To verify whether sildenafil is effective in type 1 premenopausal women affected by sexual arousal disorder (SAD)" 12/01/2003 - "Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study." 10/01/2001 - "The goal of this pilot study was to determine safety and efficacy of sildenafil for use in women with sexual arousal disorder (SAD)" 08/01/2006 - "PURPOSE: To develop a model to explore the dose-response of sildenafil citrate in patients with female sexual arousal disorder (FSAD) based on telephone sexual activity daily diary (TSADD) data obtained in double-blind, placebo controlled clinical studies" Order ALL the reference details at left...
3.	Estrogens (Estrogen)FDA Link 09/01/2006 - "DESIGN: A multicenter, randomized, double-blind, placebo-controlled, parallel-group trial was conducted in naturally menopausal women with hypoactive sexual desire disorder receiving a stable dose of oral estrogen with or without progestin (N = 549)" 10/01/2007 - "A new female androgen patch has been licensed in Europe for treatment of low libido causing distress (hypoactive sexual desire disorder) in surgically menopaused women on estrogen therapy" 07/01/2004 - "Systemic estrogen/estrogen progestin therapy alleviates climacteric symptoms but there is no evidence that this therapy specifically improves hypoactive sexual desire disorder (HSDD) in premenopausal or postmenopausal women" 12/19/2005 - "In phase 3 trials, a testosterone transdermal matrix patch has been shown to be effective in treatment of hypoactive sexual desire disorder in menopausal women on estrogen therapy" 03/01/2007 - "The transdermal testosterone patch is an effective treatment for hypoactive sexual desire disorder in surgically postmenopausal women receiving concomitant estrogen therapy" Order ALL the reference details at left...
4.	Imipramine (Janimine)FDA LinkGeneric 01/01/1996 - "It appears that imipramine might be beneficial for some patients with thioridazine-induced male orgasmic disorder." 01/01/1996 - "In this pilot study, eight male schizophrenic patients who complained of orgasmic disorder, compatible with probable retrograde ejaculation during thioridazine treatment, were given concomitant low-dose imipramine (25-50 mg at bedtime)" 01/01/1996 - "Low-dose imipramine for thioridazine-induced male orgasmic disorder." 01/01/1969 - "Treatment with Antideprein (Tofranil) and Napoton (Librium) were not effective, but stopping Lyndiol improved the depression, frigidity, and partially improved the obsessive-phobic behavior" Order ALL the reference details at left...
5.	Bupropion (Wellbutrin)FDA LinkGeneric 01/01/1987 - "Sixty female and male outpatients with psychosexual dysfunction (sexual aversion/inhibited sexual desire, inhibited sexual excitement, and/or inhibited orgasm) participated in a comparison of the efficacy of bupropion hydrochloride vs placebo" 06/01/2004 - "Premenopausal women meeting operational criteria for idiopathic, acquired, global hypoactive sexual desire disorder were studied in a randomized, double-blind, placebo-controlled, multiple-site escalating dose 112-day trial of bupropion sustained release" 06/01/2004 - "Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women." 11/01/2003 - "Bupropion may have a beneficial effect on orgasm attainment in women with hypoactive sexual desire disorder." 12/01/2001 - "Sexual arousal disorder, orgasmic dysfunction, and sexual desire disorder occurred less with bupropion than with SSRIs, with relative risks of 0.46 (95% CI 0.26 to 0.83), 0.22 (95% CI 0.12 to 0.40), and 0.65 (95% CI 0.51 to 0.84), respectively" Order ALL the reference details at left...
6.	ApomorphineIBA 05/01/2004 - "OBJECTIVES: To verify whether apomorphine SL is effective in premenopausal women affected by arousal disorder with hypoactive sexual desire disorder" 05/01/2004 - "Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder." 04/01/1997 - "A similar pattern of psychosexual disorders has been observed after long-term treatment with levodopa therapy in four male parkinsonian patients treated with apomorphine for severe on-off motor fluctuations" Order ALL the reference details at left...
7.	Biological Markers (Surrogate Marker)IBA 01/01/2003 - "These MRI techniques may also prove useful as a surrogate end point marker for testing efficacy of future new treatments for women with sexual arousal disorder." Order ALL the reference details at left...
8.	Thioridazine (Mellaril)FDA LinkGeneric 01/01/1996 - "Male orgasmic disorder is commonly encountered among patients treated with thioridazine" 01/01/1996 - "It appears that imipramine might be beneficial for some patients with thioridazine-induced male orgasmic disorder." 01/01/1996 - "In this pilot study, eight male schizophrenic patients who complained of orgasmic disorder, compatible with probable retrograde ejaculation during thioridazine treatment, were given concomitant low-dose imipramine (25-50 mg at bedtime)" 01/01/1996 - "Low-dose imipramine for thioridazine-induced male orgasmic disorder." Order ALL the reference details at left...
9.	Chlordiazepoxide (Elenium)FDA LinkGeneric 01/01/1969 - "Treatment with Antideprein (Tofranil) and Napoton (Librium) were not effective, but stopping Lyndiol improved the depression, frigidity, and partially improved the obsessive-phobic behavior" Order ALL the reference details at left...
10.	NoracyclineIBA 01/01/1969 - "Treatment with Antideprein (Tofranil) and Napoton (Librium) were not effective, but stopping Lyndiol improved the depression, frigidity, and partially improved the obsessive-phobic behavior" Order ALL the reference details at left...

Therapies and Procedures

1.	Ovariectomy (Oophorectomy) 05/01/2005 - "METHODS: Five hundred thirty-three women with hypoactive sexual desire disorder who had undergone previous hysterectomy and bilateral oophorectomy were enrolled in a 24-week, multicenter, double-blind, placebo-controlled trial" 06/01/2008 - "RESULTS: Randomized trials have demonstrated an improvement in sexual function with testosterone in postmenopausal women with hypoactive sexual desire disorder, particularly after oophorectomies" 07/01/1999 - "Three cases of women who had undergone a total abdominal hysterectomy with bilateral oophorectomy with complaints consistent with female hypoactive sexual desire disorder and free testosterone levels of < 2.0 pg/ml are presented" 05/01/2006 - "OBJECTIVE: Evaluation of the use of testosterone therapy for hypoactive sexual desire disorder (HSDD) after oophorectomy has mostly involved women treated with oral estrogen preparations" 05/01/2005 - "The sexual medicine community watched with interest as the Food and Drug Administration (FDA) considered the Proctor & Gamble new drug application for Intrinsa (a testosterone patch for hypoactive sexual desire disorder for women who had undergone surgical castration via bilateral oophorectomy)" Order ALL the reference details at left...
2.	Hysterectomy 01/28/1978 - "The problem of psychosexual disorders following hysterectomy is reviewed" 05/01/2005 - "METHODS: Five hundred thirty-three women with hypoactive sexual desire disorder who had undergone previous hysterectomy and bilateral oophorectomy were enrolled in a 24-week, multicenter, double-blind, placebo-controlled trial" 01/01/1993 - "OBJECTIVE: To assess the prevalence and severity of psychosexual dysfunction in women treated for cancer of the cervix and vulva by radical vulvectomy, Wertheim's hysterectomy and pelvic exenteration; and to identify the risk factors for sexual morbidity and ways in which it might be reduced" 07/01/1999 - "Three cases of women who had undergone a total abdominal hysterectomy with bilateral oophorectomy with complaints consistent with female hypoactive sexual desire disorder and free testosterone levels of < 2.0 pg/ml are presented" Order ALL the reference details at left...
3.	Hypnosis (Mesmerism) 03/01/1975 - "Successful treatment of frigidity through hypnosis." 01/20/1974 - "Hypnosis therapy for the cure of frigidity]" 01/01/1974 - "Hypnosis and frigidity." 01/01/2005 - "A discussion of sexual dysfunction at this end of the continuum and cases of Hypoactive Sexual Desire Disorder and Vaginismus demonstrate the clinical effectiveness of an approach combining hypnosis and ego-state therapy to facilitate healthy adaptive differentiation." 07/01/1971 - "Marital crisis intervention: hypnosis in impotence-frigidity cases." Order ALL the reference details at left...
4.	Contraception (Birth Control) 04/20/1980 - "In many adult women the use of OC (oral contraception) is in serious conflict with their unconscious desire for a child; such conflict is often cause of psychological problems and also of physiological ones, such as frigidity" 01/01/1973 - "Opinions were expressed that it is inappropriate to consider contraception from a psychological viewpoint, since it is part of a revolution toward a better life; that some psychological difficulties come from the doctor having preferences for certain methods; that the pill does not cause frigidity but is often blamed for preexisting problems; that the press frightens women away from taking the pill; that physicians should prescribe contraception to minors without seeking parental consent (unlawful in France)." 06/01/1989 - "Although these media show prostitution, homosexuality, rape, frigidity, menopause, abortion, infidelity, divorce, and impotence, there is little about birth control, self- control, abstinence, or responsibility" 01/01/1975 - "Pathological conduct that compromises contraception includes sexual inhibition, frigidity, homosexuality, phobias, obsessions, and hysteria" 02/01/1991 - "Symptoms after an abortion may include frigidity, vaginismus, dyspareunia, pain, or poor tolerance of contraception desired at the conscious level" Order ALL the reference details at left...
5.	Transplants (Transplant) 12/01/2005 - "Although rarely seen in organ transplant clinics, the presence of psychosexual disorders can result in both criminal charges and harsh societal reactions" 12/01/1998 - "The procedure is based on the use of dermo-fat free graft taken from the cruro-gluteal area and allows a penile lengthening varying from 2.5 to 3 cm. This technique can be performed in patients with the so-called "small penises" and psychosexual dysfunctions." Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Psychological Sexual Dysfunctions

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 14 Outcomes
Top 53 Key Drugs and Biologics
Top 16 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>